89. árgangur 2003, 48. fylgirit, Page 47

In particular, the importance of helping the patient to develop and test alternative, non-catastrophic interpreta- LÆKNABLAÐIÐ / FYLGIRIT 48 2003/89 47

89. árgangur 2003, 48. fylgirit, Page 48

Beck's Depression Inventory (BDI) and Symptom Checklist 90-R (SCL-90-R) were used to assess treatment results. 48 LæKNABLAÐIÐ / FYLGIRIT 48 2003/89 Results: Eight

89. árgangur 2003, 48. fylgirit, Page 49

LÆKNABLAÐIÐ / FYLGIRIT 48 2003/89 49

89. árgangur 2003, 48. fylgirit, Page 57

LÆKNABLAÐIÐ / FYLGIRIT 48 2003/89 57

89. árgangur 2003, 48. fylgirit, Page 60

Tlie use of these services is highest in the capital area, 1.7 visits per 60 LÆKNABLAÐIÐ / FYLGIRIT 48 2003/89

89. árgangur 2003, 48. fylgirit, Page 61

LÆKNABLAÐIÐ / FYLGIRIT 48 2 0 0 3/8 9 61

89. árgangur 2003, 48. fylgirit, Page 62

only appear in the form of sleep disturbances without other significant complaints (recurrent luteal phase insomnia) in 31% of reproductive age females. 62 LæKNABLAÐIÐ

89. árgangur 2003, 48. fylgirit, Page 64

Conclusions: To summarize, both treatments yielded a satisfactory 64 LÆKNABLAÐIÐ / FYLGIRIT 48 2003/89

89. árgangur 2003, 48. fylgirit, Page 65

The proportion of escitalopram responders (>50% reduction in MADRS) and remitters (MADRS <12) at LÆKNABLAÐIÐ / FYLGIRIT 48 2 0 03/8 9 6 5

89. árgangur 2003, 48. fylgirit, Page 67

Stefánssoni 'Department of Neurology and ZDepartment of Psychiatry, Landspitali University Hospital, Iceland annahho@landspitali.is LÆKNABLAÐIÐ / FYLGIRIT 48